INSTITUTE FOR ORTHOPAEDIC SURGERY — History
CCN 360263 | 3-year financial timeline | COVID resilience: 38/100
🛡️ Public data only — no PHI permitted on this instance.
$56M
Latest Revenue (FY2022)
+1.6%
Revenue CAGR (3yr)
39.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $54M | $56M | $56M | -0.3% | +1.6% |
| Operating Expenses | $28M | $31M | $34M | +9.6% | +9.0% |
| Operating Margin | 47.5% | 45.0% | 39.5% | -12.2% | -8.8% |
| Net Income | $26M | $25M | $22M | -12.5% | -7.3% |
| Licensed Beds | 12 | 12 | 12 | +0.0% | +0.0% |
| Total Patient Days | 1,811 | 1,485 | 1,056 | -28.9% | -23.6% |
| Medicare Day % | 44% | 47% | 51% | +7.1% | +6.7% |
| Medicaid Day % | 4% | 3% | 2% | -49.4% | -31.1% |
COVID Impact & Recovery
Resilience Score: 38/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: +3.2% ($54M → $56M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+1.6%
This Hospital
+7.6%
State Avg
Latest Margin
39.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $56M | 35.5% |
| FY2024 (proj) | $57M | 31.5% |
| FY2025 (proj) | $58M | 27.6% |